These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18316359)

  • 1. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
    Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
    Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
    Zhu X; Wu YB; Zhou J; Kang DM
    Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
    Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
    Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver.
    Park JM; Kim TH; Bae JS; Kim MY; Kim KS; Ahn YH
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):329-34. PubMed ID: 21078299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
    J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.
    Qadri I; Choudhury M; Rahman SM; Knotts TA; Janssen RC; Schaack J; Iwahashi M; Puljak L; Simon FR; Kilic G; Fitz JG; Friedman JE
    J Biol Chem; 2012 Oct; 287(44):37340-51. PubMed ID: 22955269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
    Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
    [No Abstract]   [Full Text] [Related]  

  • 10. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development.
    Sekine K; Chen YR; Kojima N; Ogata K; Fukamizu A; Miyajima A
    EMBO J; 2007 Aug; 26(15):3607-15. PubMed ID: 17627282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
    Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
    Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.
    Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
    Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
    Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.
    Bernsmeier C; Calabrese D; Heim MH; Duong HT
    J Viral Hepat; 2014 Jan; 21(1):9-18. PubMed ID: 24329853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
    Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
    J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis.
    Konopelska S; Kienitz T; Quinkler M
    Obesity (Silver Spring); 2011 Dec; 19(12):2322-6. PubMed ID: 21593806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.
    Samuel VT; Choi CS; Phillips TG; Romanelli AJ; Geisler JG; Bhanot S; McKay R; Monia B; Shutter JR; Lindberg RA; Shulman GI; Veniant MM
    Diabetes; 2006 Jul; 55(7):2042-50. PubMed ID: 16804074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.
    Titchenell PM; Chu Q; Monks BR; Birnbaum MJ
    Nat Commun; 2015 May; 6():7078. PubMed ID: 25963408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gegen Qinlian Decoction Ameliorates Hepatic Insulin Resistance by Silent Information Regulator1 (SIRT1)-Dependent Deacetylation of Forkhead Box O1 (FOXO1).
    Sui M; Chen G; Mao X; Wei X; Chen Y; Liu C; Fan Y
    Med Sci Monit; 2019 Nov; 25():8544-8553. PubMed ID: 31719515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.